EUR 17.04
(-0.81%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 575.64 Million EUR | -44.77% |
2022 | 1.04 Billion EUR | 18.88% |
2021 | 876.77 Million EUR | -15.06% |
2020 | 1.03 Billion EUR | -2.49% |
2019 | 1.05 Billion EUR | 7.79% |
2018 | 982 Million EUR | 6.74% |
2017 | 919.98 Million EUR | 2.41% |
2016 | 898.36 Million EUR | 7.37% |
2015 | 836.68 Million EUR | 18.62% |
2014 | 705.32 Million EUR | 8.23% |
2013 | 651.71 Million EUR | -2.21% |
2012 | 666.47 Million EUR | 6.82% |
2011 | 623.9 Million EUR | -6.27% |
2010 | 665.6 Million EUR | -15.28% |
2009 | 785.61 Million EUR | 2.04% |
2008 | 769.93 Million EUR | -15.61% |
2007 | 912.32 Million EUR | 5.03% |
2006 | 868.6 Million EUR | 21.16% |
2005 | 716.88 Million EUR | 24.22% |
2004 | 577.09 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | -175.71 Million EUR | -124.24% |
2024 Q1 | 724.91 Million EUR | 151.19% |
2023 Q1 | 741.22 Million EUR | 138.01% |
2023 Q4 | 288.59 Million EUR | 239.11% |
2023 FY | 575.64 Million EUR | -44.77% |
2023 Q3 | -207.46 Million EUR | -172.16% |
2023 Q2 | 287.48 Million EUR | -61.22% |
2022 Q2 | 282.86 Million EUR | 0.0% |
2022 FY | 1.04 Billion EUR | 18.88% |
2022 Q4 | 311.41 Million EUR | 0.0% |
2021 Q3 | 134.48 Million EUR | -49.28% |
2021 FY | 876.77 Million EUR | -15.06% |
2021 Q1 | 134.48 Million EUR | -41.63% |
2021 Q2 | 265.15 Million EUR | 97.17% |
2021 Q4 | 242.66 Million EUR | 80.45% |
2020 Q2 | 304.83 Million EUR | 95.82% |
2020 FY | 1.03 Billion EUR | -2.49% |
2020 Q4 | 230.4 Million EUR | 48.01% |
2020 Q1 | 155.66 Million EUR | -45.8% |
2020 Q3 | 155.66 Million EUR | -48.93% |
2019 Q4 | 287.22 Million EUR | 208.54% |
2019 FY | 1.05 Billion EUR | 7.79% |
2019 Q2 | 276.05 Million EUR | 204.32% |
2019 Q1 | -264.63 Million EUR | -7.79% |
2019 Q3 | -264.63 Million EUR | -195.86% |
2018 Q3 | -245.5 Million EUR | 0.0% |
2018 FY | 982 Million EUR | 6.74% |
2018 Q1 | -245.5 Million EUR | -6.74% |
2018 Q2 | -245.5 Million EUR | 0.0% |
2018 Q4 | -245.5 Million EUR | 0.0% |
2017 Q4 | -229.99 Million EUR | 0.0% |
2017 FY | 919.98 Million EUR | 2.41% |
2017 Q2 | -229.99 Million EUR | 0.0% |
2017 Q1 | -229.99 Million EUR | -2.41% |
2017 Q3 | -229.99 Million EUR | 0.0% |
2016 Q1 | -224.59 Million EUR | -7.37% |
2016 Q4 | -224.59 Million EUR | 0.0% |
2016 Q3 | -224.59 Million EUR | 0.0% |
2016 Q2 | -224.59 Million EUR | 0.0% |
2016 FY | 898.36 Million EUR | 7.37% |
2015 Q1 | -209.17 Million EUR | -18.62% |
2015 Q4 | -209.17 Million EUR | 0.0% |
2015 Q3 | -209.17 Million EUR | 0.0% |
2015 Q2 | -209.17 Million EUR | 0.0% |
2015 FY | 836.68 Million EUR | 18.62% |
2014 Q3 | -176.33 Million EUR | 0.0% |
2014 FY | 705.32 Million EUR | 8.23% |
2014 Q4 | -176.33 Million EUR | 0.0% |
2014 Q2 | -176.33 Million EUR | 0.0% |
2014 Q1 | -176.33 Million EUR | -8.23% |
2013 FY | 651.71 Million EUR | -2.21% |
2013 Q3 | -162.92 Million EUR | 0.0% |
2013 Q4 | -162.92 Million EUR | 0.0% |
2013 Q2 | -162.92 Million EUR | 0.0% |
2013 Q1 | -162.92 Million EUR | 2.21% |
2012 Q1 | -166.61 Million EUR | -6.82% |
2012 Q3 | -166.61 Million EUR | 0.0% |
2012 FY | 666.47 Million EUR | 6.82% |
2012 Q2 | -166.61 Million EUR | 0.0% |
2012 Q4 | -166.61 Million EUR | 0.0% |
2011 FY | 623.9 Million EUR | -6.27% |
2011 Q2 | -155.97 Million EUR | 0.0% |
2011 Q1 | -155.97 Million EUR | -364.18% |
2011 Q4 | -155.97 Million EUR | 0.0% |
2011 Q3 | -155.97 Million EUR | 0.0% |
2010 Q2 | 59.04 Million EUR | 0.0% |
2010 Q4 | 59.04 Million EUR | 0.0% |
2010 FY | 665.6 Million EUR | -15.28% |
2010 Q1 | 59.04 Million EUR | 5.6% |
2010 Q3 | 59.04 Million EUR | 0.0% |
2009 Q4 | 55.91 Million EUR | 0.0% |
2009 Q3 | 55.91 Million EUR | 0.0% |
2009 Q2 | 55.91 Million EUR | 0.0% |
2009 Q1 | 55.91 Million EUR | 21.63% |
2009 FY | 785.61 Million EUR | 2.04% |
2008 Q3 | 45.96 Million EUR | 0.0% |
2008 FY | 769.93 Million EUR | -15.61% |
2008 Q2 | 45.96 Million EUR | 0.0% |
2008 Q1 | 45.96 Million EUR | -22.77% |
2008 Q4 | 45.96 Million EUR | 0.0% |
2007 Q2 | 59.52 Million EUR | 0.0% |
2007 Q3 | 59.52 Million EUR | 0.0% |
2007 FY | 912.32 Million EUR | 5.03% |
2007 Q4 | 59.52 Million EUR | 0.0% |
2007 Q1 | 59.52 Million EUR | 4330.61% |
2006 Q2 | -1.4 Million EUR | 0.0% |
2006 Q3 | -1.4 Million EUR | 0.0% |
2006 Q4 | -1.4 Million EUR | 0.0% |
2006 Q1 | -1.4 Million EUR | 23.46% |
2006 FY | 868.6 Million EUR | 21.16% |
2005 Q1 | -1.83 Million EUR | -29.32% |
2005 Q4 | -1.83 Million EUR | 0.0% |
2005 Q3 | -1.83 Million EUR | 0.0% |
2005 FY | 716.88 Million EUR | 24.22% |
2005 Q2 | -1.83 Million EUR | 0.0% |
2004 Q4 | -1.42 Million EUR | 0.0% |
2004 Q1 | -1.42 Million EUR | 0.0% |
2004 FY | 577.09 Million EUR | 0.0% |
2004 Q3 | -1.42 Million EUR | 0.0% |
2004 Q2 | -1.42 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Naturhouse Health, S.A. | 20.24 Million EUR | -2743.931% |
Deoleo, S.A. | 170.78 Million EUR | -237.055% |